Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission.

BACKGROUND:Interventions to interrupt transmission of malaria from humans to mosquitoes represent an appealing approach to assist malaria elimination. A limitation has been the lack of systems to test the efficacy of such interventions before proceeding to efficacy trials in the field. We have previ...

Full description

Bibliographic Details
Main Authors: Paul Griffin, Cielo Pasay, Suzanne Elliott, Silvana Sekuloski, Maggy Sikulu, Leon Hugo, David Khoury, Deborah Cromer, Miles Davenport, Jetsumon Sattabongkot, Karen Ivinson, Christian Ockenhouse, James McCarthy
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-12-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC5145139?pdf=render
_version_ 1818458934782984192
author Paul Griffin
Cielo Pasay
Suzanne Elliott
Silvana Sekuloski
Maggy Sikulu
Leon Hugo
David Khoury
Deborah Cromer
Miles Davenport
Jetsumon Sattabongkot
Karen Ivinson
Christian Ockenhouse
James McCarthy
author_facet Paul Griffin
Cielo Pasay
Suzanne Elliott
Silvana Sekuloski
Maggy Sikulu
Leon Hugo
David Khoury
Deborah Cromer
Miles Davenport
Jetsumon Sattabongkot
Karen Ivinson
Christian Ockenhouse
James McCarthy
author_sort Paul Griffin
collection DOAJ
description BACKGROUND:Interventions to interrupt transmission of malaria from humans to mosquitoes represent an appealing approach to assist malaria elimination. A limitation has been the lack of systems to test the efficacy of such interventions before proceeding to efficacy trials in the field. We have previously demonstrated the feasibility of induced blood stage malaria (IBSM) infection with Plasmodium vivax. In this study, we report further validation of the IBSM model, and its evaluation for assessment of transmission of P. vivax to Anopheles stephensi mosquitoes. METHODS:Six healthy subjects (three cohorts, n = 2 per cohort) were infected with P. vivax by inoculation with parasitized erythrocytes. Parasite growth was monitored by quantitative PCR, and gametocytemia by quantitative reverse transcriptase PCR (qRT-PCR) for the mRNA pvs25. Parasite multiplication rate (PMR) and size of inoculum were calculated by linear regression. Mosquito transmission studies were undertaken by direct and membrane feeding assays over 3 days prior to commencement of antimalarial treatment, and midguts of blood fed mosquitoes dissected and checked for presence of oocysts after 7-9 days. RESULTS:The clinical course and parasitemia were consistent across cohorts, with all subjects developing mild to moderate symptoms of malaria. No serious adverse events were reported. Asymptomatic elevated liver function tests were detected in four of six subjects; these resolved without treatment. Direct feeding of mosquitoes was well tolerated. The estimated PMR was 9.9 fold per cycle. Low prevalence of mosquito infection was observed (1.8%; n = 32/1801) from both direct (4.5%; n = 20/411) and membrane (0.9%; n = 12/1360) feeds. CONCLUSION:The P. vivax IBSM model proved safe and reliable. The clinical course and PMR were reproducible when compared with the previous study using this model. The IBSM model presented in this report shows promise as a system to test transmission-blocking interventions. Further work is required to validate transmission and increase its prevalence. TRIAL REGISTRATION:Anzctr.org.au ACTRN12613001008718.
first_indexed 2024-12-14T23:06:21Z
format Article
id doaj.art-c69ef26a80be445cbc33a06ebe6523cd
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-14T23:06:21Z
publishDate 2016-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-c69ef26a80be445cbc33a06ebe6523cd2022-12-21T22:44:19ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352016-12-011012e000513910.1371/journal.pntd.0005139Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission.Paul GriffinCielo PasaySuzanne ElliottSilvana SekuloskiMaggy SikuluLeon HugoDavid KhouryDeborah CromerMiles DavenportJetsumon SattabongkotKaren IvinsonChristian OckenhouseJames McCarthyBACKGROUND:Interventions to interrupt transmission of malaria from humans to mosquitoes represent an appealing approach to assist malaria elimination. A limitation has been the lack of systems to test the efficacy of such interventions before proceeding to efficacy trials in the field. We have previously demonstrated the feasibility of induced blood stage malaria (IBSM) infection with Plasmodium vivax. In this study, we report further validation of the IBSM model, and its evaluation for assessment of transmission of P. vivax to Anopheles stephensi mosquitoes. METHODS:Six healthy subjects (three cohorts, n = 2 per cohort) were infected with P. vivax by inoculation with parasitized erythrocytes. Parasite growth was monitored by quantitative PCR, and gametocytemia by quantitative reverse transcriptase PCR (qRT-PCR) for the mRNA pvs25. Parasite multiplication rate (PMR) and size of inoculum were calculated by linear regression. Mosquito transmission studies were undertaken by direct and membrane feeding assays over 3 days prior to commencement of antimalarial treatment, and midguts of blood fed mosquitoes dissected and checked for presence of oocysts after 7-9 days. RESULTS:The clinical course and parasitemia were consistent across cohorts, with all subjects developing mild to moderate symptoms of malaria. No serious adverse events were reported. Asymptomatic elevated liver function tests were detected in four of six subjects; these resolved without treatment. Direct feeding of mosquitoes was well tolerated. The estimated PMR was 9.9 fold per cycle. Low prevalence of mosquito infection was observed (1.8%; n = 32/1801) from both direct (4.5%; n = 20/411) and membrane (0.9%; n = 12/1360) feeds. CONCLUSION:The P. vivax IBSM model proved safe and reliable. The clinical course and PMR were reproducible when compared with the previous study using this model. The IBSM model presented in this report shows promise as a system to test transmission-blocking interventions. Further work is required to validate transmission and increase its prevalence. TRIAL REGISTRATION:Anzctr.org.au ACTRN12613001008718.http://europepmc.org/articles/PMC5145139?pdf=render
spellingShingle Paul Griffin
Cielo Pasay
Suzanne Elliott
Silvana Sekuloski
Maggy Sikulu
Leon Hugo
David Khoury
Deborah Cromer
Miles Davenport
Jetsumon Sattabongkot
Karen Ivinson
Christian Ockenhouse
James McCarthy
Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission.
PLoS Neglected Tropical Diseases
title Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission.
title_full Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission.
title_fullStr Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission.
title_full_unstemmed Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission.
title_short Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission.
title_sort safety and reproducibility of a clinical trial system using induced blood stage plasmodium vivax infection and its potential as a model to evaluate malaria transmission
url http://europepmc.org/articles/PMC5145139?pdf=render
work_keys_str_mv AT paulgriffin safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT cielopasay safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT suzanneelliott safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT silvanasekuloski safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT maggysikulu safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT leonhugo safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT davidkhoury safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT deborahcromer safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT milesdavenport safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT jetsumonsattabongkot safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT karenivinson safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT christianockenhouse safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission
AT jamesmccarthy safetyandreproducibilityofaclinicaltrialsystemusinginducedbloodstageplasmodiumvivaxinfectionanditspotentialasamodeltoevaluatemalariatransmission